US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US6334997B1
(en)
*
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
EP0979306A4
(fr)
*
|
1997-02-14 |
2004-09-01 |
Univ George Washington |
Dosage destine a la mesure des taux de synthese d'adn
|
US6312450B1
(en)
|
1997-05-20 |
2001-11-06 |
Natural Vision Center, Inc. |
System and method for improving the appearance of skin
|
US6884429B2
(en)
*
|
1997-09-05 |
2005-04-26 |
Isotechnika International Inc. |
Medical devices incorporating deuterated rapamycin for controlled delivery thereof
|
EP1645565B1
(fr)
*
|
1997-10-08 |
2009-02-18 |
Isotechnika Inc. |
Analogue de la cyclosporine deuterié et luers utilisations comme agents immunomodulés
|
US20030220234A1
(en)
*
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
ES2256959T3
(es)
|
1997-10-08 |
2006-07-16 |
Isotechnika,Inc. |
Analogos de ciclosporina deuterados y no deuterados y su uso como agentes inmunomoduladores.
|
US6333342B1
(en)
*
|
1998-11-04 |
2001-12-25 |
Isotechnika, Inc |
Methods of pharmacological treatment using S(−) amlodipine
|
US6376531B1
(en)
|
1998-11-13 |
2002-04-23 |
Rupert Charles Bell |
Method of treatment using deuterium compounds
|
US7323341B1
(en)
|
1999-07-09 |
2008-01-29 |
Jasper John P |
Stable isotopic identification and method for identifying products by isotopic concentration
|
US6254594B1
(en)
|
1999-07-30 |
2001-07-03 |
Quadrivium, Llc |
Disposable light source for photothermal treatment of human tissue
|
RU2181297C2
(ru)
|
2000-06-20 |
2002-04-20 |
Эпштейн Олег Ильич |
Способ лечения патологического синдрома и лекарственное средство
|
US6579630B2
(en)
|
2000-12-07 |
2003-06-17 |
Canon Kabushiki Kaisha |
Deuterated semiconducting organic compounds used for opto-electronic devices
|
US6872408B2
(en)
*
|
2001-09-07 |
2005-03-29 |
Rupert C. Bell |
Method of treating bipolar disorders using deuterium-substituted carbonate
|
KR100951218B1
(ko)
|
2001-10-16 |
2010-04-05 |
메모리 파마슈티칼스 코포레이션 |
신경계 증후군의 치료를 위한 pde-4 억제제로서의4-(4-알콕시-3-히드록시페닐)-2-피롤리돈 유도체
|
PT1436321E
(pt)
|
2001-10-19 |
2006-10-31 |
Isotechnika Inc |
Sintese de analogos de ciclosporina
|
RU2201255C1
(ru)
*
|
2001-12-26 |
2003-03-27 |
Эпштейн Олег Ильич |
Лекарственное средство и способ регуляции сосудистого тонуса
|
DE10205432A1
(de)
*
|
2002-02-07 |
2003-08-21 |
Bdd Group Holding Ag Zug |
Deuterierte biphenylsubstituierte Spirocyclopentanimidazoline sowie diese Verbindungen enthaltende Arzneimittel
|
UA76640C2
(uk)
*
|
2002-08-02 |
2006-08-15 |
Олєг Ільіч Епштєйн |
Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
|
UA76639C2
(uk)
*
|
2002-08-02 |
2006-08-15 |
Олєг Ільіч Епштєйн |
Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
|
EP2298759A1
(fr)
|
2002-08-30 |
2011-03-23 |
Memory Pharmaceuticals Corporation |
Dérivés d'anabaseine utiles pour le traitement de maladies neurodégénératives
|
ES2405594T3
(es)
|
2002-09-25 |
2013-05-31 |
Memory Pharmaceuticals Corporation |
Idazoles, benzotiazoles y benzisotiazoles, y preparación y usos de los mismos
|
CA2506297A1
(fr)
|
2002-11-19 |
2004-06-03 |
Memory Pharmaceuticals Corporation |
Inhibiteurs de la phosphodiesterase 4
|
AU2004222306A1
(en)
*
|
2003-03-17 |
2004-09-30 |
Albany Molecular Research, Inc. |
Novel cyclosporins
|
CN1805929A
(zh)
*
|
2003-04-16 |
2006-07-19 |
记忆药物公司 |
磷酸二酯酶4抑制剂
|
AU2004232973A1
(en)
*
|
2003-04-18 |
2004-11-04 |
Memory Pharmaceuticals Corporation |
Pyrazole derivatives as phosphodiesterase 4 inhibitors
|
US20050043288A1
(en)
*
|
2003-08-21 |
2005-02-24 |
Thomas Tobin |
Composition and method for marking procaine penicillin
|
RU2253478C1
(ru)
*
|
2003-10-01 |
2005-06-10 |
Эпштейн Олег Ильич |
Средство для потенцирования лечебных эффектов - усиления действия лекарственного вещества
|
EP1952824A1
(fr)
|
2003-11-21 |
2008-08-06 |
Memory Pharmaceuticals Corporation |
Compositions et procédés de traitement utilisant des inhibiteurs calciques de type L et inhibiteurs de cholinestérase
|
BRPI0508771A
(pt)
|
2004-03-25 |
2007-08-14 |
Memory Pharm Corp |
indazóis, benzotiazóis, benzoisotiazóis, benzisoxazóis, e a preparação e usos dos mesmos
|
US7754897B2
(en)
*
|
2005-06-15 |
2010-07-13 |
Cardiome Pharma Corp. |
Synthetic processes for the preparation of aminocyclohexyl ether compounds
|
WO2005094897A2
(fr)
*
|
2004-04-01 |
2005-10-13 |
Cardiome Pharma Corp. |
Derives de composes de modulation des canaux ioniques, compositions pharmaceutiques et utilisations
|
US7705036B2
(en)
*
|
2004-04-01 |
2010-04-27 |
Cardiome Pharma Corp. |
Deuterated aminocyclohexyl ether compounds and processes for preparing same
|
US7378391B2
(en)
*
|
2004-09-29 |
2008-05-27 |
Amr Technology, Inc. |
Cyclosporin alkyne analogues and their pharmaceutical uses
|
EP1804823A4
(fr)
*
|
2004-09-29 |
2010-06-09 |
Amr Technology Inc |
Nouveaux analogues de la cyclosporine et leurs utilisations pharmaceutiques
|
US7361636B2
(en)
*
|
2004-10-06 |
2008-04-22 |
Amr Technology, Inc. |
Cyclosporin alkynes and their utility as pharmaceutical agents
|
US7432266B2
(en)
*
|
2004-10-15 |
2008-10-07 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors
|
US7585882B2
(en)
*
|
2004-10-20 |
2009-09-08 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors
|
US8692002B2
(en)
*
|
2004-11-18 |
2014-04-08 |
Cardiome Pharma Corp. |
Synthetic process for aminocyclohexyl ether compounds
|
NZ565078A
(en)
*
|
2005-07-26 |
2010-03-26 |
Nycomed Gmbh |
Deuterated proton pump inhibitors such as omeprazole
|
AR054583A1
(es)
*
|
2005-07-26 |
2007-06-27 |
Altana Pharma Ag |
Pantoprazol isotopicamente sustituido
|
US7863274B2
(en)
|
2005-07-29 |
2011-01-04 |
Concert Pharmaceuticals Inc. |
Deuterium enriched analogues of tadalafil as PDE5 inhibitors
|
BRPI0615973A2
(pt)
*
|
2005-07-29 |
2011-05-31 |
Concert Pharmaceuticals Inc |
novos derivados de benzo [d] [1,3] - dioxol
|
CA2624179A1
(fr)
|
2005-10-06 |
2007-04-12 |
Auspex Pharmaceuticals, Inc. |
Inhibiteurs deuteries d'atpase h+,k+ gastrique ayant des proprietes therapeutiques renforcees
|
EP1954669B1
(fr)
|
2005-12-01 |
2015-07-08 |
Auspex Pharmaceuticals, Inc. |
Phénétylamines substituées à l activité sérotoninergique et/ou norépinephrinergique
|
RU2309732C1
(ru)
*
|
2006-03-13 |
2007-11-10 |
Олег Ильич Эпштейн |
Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
|
US7696165B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
US7696166B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
|
AU2007267612A1
(en)
*
|
2006-05-26 |
2007-12-06 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted carboxylic acid compounds
|
WO2007142945A2
(fr)
|
2006-05-30 |
2007-12-13 |
Jasper John P |
processus de traçage entre des précurseurs et des produits en utilisant des relations isotopiques
|
US7772248B2
(en)
|
2006-06-05 |
2010-08-10 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
|
EP2023721A2
(fr)
*
|
2006-06-05 |
2009-02-18 |
Auspex Pharmaceuticals Inc. |
Préparation et utilité d'analogues d'érythromycine substitués
|
US8299248B2
(en)
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
CA2660659A1
(fr)
*
|
2006-08-08 |
2008-02-21 |
Auspex Pharmaceuticals, Inc. |
Preparation et utilite de composes quinazoliniques substitues avec des effets alpha-adrenergiques bloquants
|
CA2661302A1
(fr)
|
2006-08-16 |
2008-02-21 |
Auspex Pharmaceuticals, Inc. |
Preparation et utilite d'analgesiques opioides
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
US8044041B2
(en)
*
|
2006-11-15 |
2011-10-25 |
Forest Laboratories Holdings Limited |
Phthalazine derivatives as inhibitors of protein kinase
|
WO2008063600A2
(fr)
*
|
2006-11-17 |
2008-05-29 |
Concert Pharmaceuticals Inc. |
Dérivés de triazolyle tropane
|
US20080146573A1
(en)
*
|
2006-12-04 |
2008-06-19 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted oxzolidinones
|
US8343950B2
(en)
|
2006-12-15 |
2013-01-01 |
Concert Pharmaceuticals, Inc. |
Quinazoline derivatives and methods of treatment
|
WO2008088727A2
(fr)
*
|
2007-01-12 |
2008-07-24 |
Concert Pharmaceuticals, Inc. |
Antagonistes du récepteur de l'endothéline
|
US8080549B2
(en)
|
2007-01-12 |
2011-12-20 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
WO2008106125A2
(fr)
|
2007-02-26 |
2008-09-04 |
Concert Pharmaceuticals, Inc. |
Antagonistes du récepteur alpha 1a-adrénergique
|
ATE509015T1
(de)
|
2007-03-07 |
2011-05-15 |
Concert Pharmaceuticals Inc |
Deuterierte piperazinderivate als verbindungen gegen angina
|
DK2125698T3
(en)
|
2007-03-15 |
2016-11-07 |
Auspex Pharmaceuticals Inc |
Deuterated d9-VENLAFAXINE
|
ES2559838T3
(es)
|
2007-03-16 |
2016-02-16 |
Concert Pharmaceuticals, Inc. |
Inhibidores de proteína de transferencia de ésteres de colesterol
|
BRPI0809740A2
(pt)
|
2007-04-10 |
2014-11-04 |
Auspex Pharmaceuticals Inc |
"composto, composição farmacêutica, método para tratamento, prevenção ou melhora de um ou mais sintomas de uma desordem mediada pela endotelina, método de inibição da ligação de uma endotelina para um receptor et ou et e, método para modular atividade mediada pelo recptor de endotelina"
|
US8349817B2
(en)
|
2007-04-25 |
2013-01-08 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
EP2527336A1
(fr)
|
2007-04-25 |
2012-11-28 |
Concert Pharmaceuticals Inc. |
Analogues deutérés de cilostazol
|
JP2010525081A
(ja)
|
2007-04-26 |
2010-07-22 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
重水素標識ケタミン
|
DK2345653T3
(da)
|
2007-05-01 |
2013-04-08 |
Concert Pharmaceuticals Inc |
Morphinanforbindelser
|
PT3825306T
(pt)
|
2007-05-01 |
2023-07-24 |
Sun Pharmaceutical Ind Inc |
Compostos de morfinano
|
US7820666B2
(en)
|
2007-05-08 |
2010-10-26 |
Concert Pharmaceuticals, Inc. |
Tetrahydrotriazolopyrazine derivatives and uses thereof
|
US20080280970A1
(en)
|
2007-05-08 |
2008-11-13 |
Czarnik Anthony W |
Deuterium-enriched atorvastatin
|
HUP0700353A2
(en)
*
|
2007-05-18 |
2008-12-29 |
Richter Gedeon Nyrt |
Metabolites of (thio)carbamoyl-cyclohexane derivatives
|
US7531685B2
(en)
*
|
2007-06-01 |
2009-05-12 |
Protia, Llc |
Deuterium-enriched oxybutynin
|
WO2008151179A2
(fr)
|
2007-06-04 |
2008-12-11 |
Auspex Pharmaceuticals, Inc. |
Phénéthylamines substituées
|
WO2008156632A1
(fr)
|
2007-06-12 |
2008-12-24 |
Concert Pharmaceuticals, Inc. |
Dérivés d'azapeptides
|
US20080312318A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Protia, Llc |
Deuterium-enriched escitalopram
|
US20080318964A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Protia, Llc |
Deuterium-enriched eszopiclone
|
KR101583737B1
(ko)
|
2007-06-20 |
2016-01-11 |
오스펙스 파마슈티칼스, 인코포레이티드 |
섬유증 저해제로서의 치환된 n-아릴 피리디논
|
US7915309B2
(en)
|
2007-06-20 |
2011-03-29 |
Protia, Llc |
Deuterium-enriched oseltamivir
|
CA2702317A1
(fr)
|
2007-07-09 |
2009-01-15 |
Concert Pharmaceuticals, Inc. |
Nouveaux derives de pyrimidinecarboxamide
|
CN101835749A
(zh)
*
|
2007-07-30 |
2010-09-15 |
奥斯拜客斯制药有限公司 |
取代的吲哚
|
ES2425183T3
(es)
|
2007-08-14 |
2013-10-11 |
Concert Pharmaceuticals Inc. |
Derivados de oxazolidinonas sustituidas
|
US20090062182A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched dalbavancin
|
US7767860B2
(en)
|
2007-09-06 |
2010-08-03 |
Auspex Pharmaceuticals, Inc |
Substituted amino alcohols
|
US20090069395A1
(en)
*
|
2007-09-09 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched famotidine
|
US8288414B2
(en)
|
2007-09-12 |
2012-10-16 |
Deuteria Pharmaceuticals, Inc. |
Deuterium-enriched lenalidomide
|
US8304435B2
(en)
|
2007-09-12 |
2012-11-06 |
Deuteria Pharmaceuticals Inc. |
Deuterium-enriched donepezil
|
AU2008299931B2
(en)
|
2007-09-12 |
2013-01-10 |
Concert Pharmaceuticals, Inc. |
Deuterated 4 -oxoquinoline derivatives for the treatment of HIV infection
|
US8669268B2
(en)
|
2007-09-12 |
2014-03-11 |
Deuterx, Llc |
Deuterium-enriched prasugrel
|
US20090076161A1
(en)
|
2007-09-13 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched bupropion
|
US7919516B2
(en)
|
2007-09-13 |
2011-04-05 |
Protia, Llc |
Deuterium-enriched ondansetron
|
CA2698808A1
(fr)
|
2007-09-13 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Synthese de benzo[d][1,3]dioxoles et de catechols deuteries, ainsi que de leurs derives
|
US8026249B2
(en)
|
2007-09-14 |
2011-09-27 |
Deutena Pharmaceuticals, Inc. |
Deuterium-enriched topotecan
|
US7776866B2
(en)
|
2007-09-15 |
2010-08-17 |
Protia, Llc |
Deuterium-enriched risperidone
|
US7842675B2
(en)
|
2007-09-15 |
2010-11-30 |
Protia, Llc |
Deuterium-enriched capecitabine
|
US7956080B2
(en)
|
2007-09-25 |
2011-06-07 |
Protra, LLC |
Deuterium-enriched SDX-101
|
US8722710B2
(en)
|
2007-09-26 |
2014-05-13 |
Deuterx, Llc |
Deuterium-enriched pioglitazone
|
US20090082259A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched octreotide
|
US20090105338A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Protia, Llc |
Deuterium-enriched gabexate mesylate
|
WO2009051782A1
(fr)
*
|
2007-10-18 |
2009-04-23 |
Concert Pharmaceuticals Inc. |
Étravirine deutérée
|
US8592487B2
(en)
|
2007-10-26 |
2013-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
WO2009067225A2
(fr)
*
|
2007-11-20 |
2009-05-28 |
Concert Pharmaceuticals, Inc. |
Peptides pour le traitement d'infections par le vhc
|
US7875610B2
(en)
*
|
2007-12-03 |
2011-01-25 |
Richter Gedeon Nyrt. |
Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
|
ES2396366T3
(es)
|
2007-12-10 |
2013-02-21 |
Concert Pharmaceuticals Inc. |
Inhibidores heterocíclicos de quinasas
|
WO2009079637A1
(fr)
*
|
2007-12-18 |
2009-06-25 |
Concert Pharmaceuticals, Inc. |
Dérivés de tétrahydroisoquinoline
|
US8609673B2
(en)
|
2008-01-22 |
2013-12-17 |
Concert Pharmaceuticals, Inc. |
Vandetanib derivatives
|
WO2009094216A1
(fr)
|
2008-01-22 |
2009-07-30 |
Concert Pharmaceuticals Inc. |
Dérivés de géfitinib
|
JP5496915B2
(ja)
|
2008-02-13 |
2014-05-21 |
シージーアイ ファーマシューティカルズ,インコーポレーテッド |
6−アリール−イミダゾ[1,2−a]ピラジン誘導体、その製造方法、及びその使用方法
|
KR101563383B1
(ko)
*
|
2008-02-21 |
2015-10-26 |
미쓰비시 타나베 파마 코퍼레이션 |
경구 투여용 고형 제제
|
MX2010009300A
(es)
|
2008-02-29 |
2010-11-05 |
Concert Pharmaceuticals Inc |
Derivados de xantina substituidos.
|
CA2715036A1
(fr)
*
|
2008-03-14 |
2009-09-17 |
Retrotope, Inc. |
Therapies contre le cancer utilisant de la lysine substituee isotopiquement
|
RU2010142936A
(ru)
*
|
2008-03-20 |
2012-04-27 |
Форест Лабораториес Холдингс Лимитед (Bm) |
НОВЫЕ ПРОИЗВОДНЫЕ ПИПЕРАЗИНА КАК ИНГИБИТОРЫ СТЕАРОИЛ-КоА ДЕСАТУРАЗЫ
|
AU2009225441B2
(en)
*
|
2008-03-20 |
2012-12-13 |
Forest Laboratories Holdings Limited |
Novel piperidine derivatives as inhibitors of stearoyl-CoA desaturase
|
US8367674B2
(en)
|
2008-04-17 |
2013-02-05 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
WO2009148600A2
(fr)
*
|
2008-06-06 |
2009-12-10 |
Concert Pharmaceuticals, Inc. |
Composés à base de lysine deutérée
|
WO2009154754A2
(fr)
|
2008-06-17 |
2009-12-23 |
Concert Pharmaceuticals, Inc. |
Synthèse de dérivés de morpholine deutérés
|
US20100016297A1
(en)
*
|
2008-06-24 |
2010-01-21 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
WO2009158005A1
(fr)
*
|
2008-06-27 |
2009-12-30 |
Concert Pharmaceuticals, Inc. |
Composés à base de benzazépinone
|
WO2010005520A2
(fr)
*
|
2008-06-30 |
2010-01-14 |
Concert Pharmaceuticals, Inc. |
Dérivés de 2-alkyl-3-acylpyrazolo[1,5-a]pyridines
|
WO2010002451A1
(fr)
*
|
2008-07-01 |
2010-01-07 |
Concert Pharmaceuticals, Inc. |
Dérivés de naphtyridine
|
US20100022581A1
(en)
*
|
2008-07-02 |
2010-01-28 |
Memory Pharmaceuticals Corporation |
Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity
|
BRPI0916769A2
(pt)
*
|
2008-07-15 |
2017-09-26 |
Theracos Inc |
derivados de benzilbenzeno deuterados e métodos de uso
|
MY156288A
(en)
|
2008-07-16 |
2016-01-29 |
Richter Gedeon Nyrt |
Pharmaceutical formulations containing dopamine receptor ligands.
|
US20100093758A1
(en)
*
|
2008-07-23 |
2010-04-15 |
Auspex Pharmaceuticals, Inc. |
Pyridine sulfonamide modulators of endothelin-a receptor
|
US20100029629A1
(en)
*
|
2008-07-25 |
2010-02-04 |
Memory Pharmaceuticals Corporation |
Acyclic compounds having 5-ht6 receptor affinity
|
EP2331140B1
(fr)
|
2008-08-11 |
2018-07-04 |
Nektar Therapeutics |
Conjugués d'alcanoate polymère à multiples bras
|
WO2010019560A1
(fr)
*
|
2008-08-12 |
2010-02-18 |
Concert Pharmaceuticals Inc. |
Dérivés deutérés de donépézil
|
US20100221221A1
(en)
*
|
2008-08-12 |
2010-09-02 |
Concert Pharmaceuticals Inc. |
N-phenyl-2-pyrimidineamine derivatives
|
US20100056531A1
(en)
*
|
2008-08-22 |
2010-03-04 |
Memory Pharmaceuticals Corporation |
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
|
US20100074973A1
(en)
*
|
2008-08-27 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Thioxanthene modulators of dopamine d2 receptors
|
CN102176826B
(zh)
|
2008-08-29 |
2014-08-20 |
康瑟特制药公司 |
取代的三唑并哒嗪衍生物
|
AU2009288108B2
(en)
*
|
2008-09-03 |
2013-10-17 |
Teva Pharmaceutical Industries, Ltd. |
2-oxo-1,2-dihydro-quinoline modulators of immune function
|
US8704001B2
(en)
|
2008-09-16 |
2014-04-22 |
Concert Pharmaceuticals, Inc. |
Deuterated 2-amino-3-hydroxypropanoic acid derivatives
|
CN102186848B
(zh)
|
2008-09-18 |
2014-11-12 |
奥斯拜客斯制药有限公司 |
囊泡单胺转运体2的苯并喹啉抑制剂
|
ES2402088T3
(es)
|
2008-09-19 |
2013-04-26 |
Concert Pharmaceuticals Inc. |
Compuestos de morfinano
|
AU2013204067B2
(en)
*
|
2008-09-19 |
2014-02-27 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
AU2015258262B2
(en)
*
|
2008-09-19 |
2016-08-18 |
Concert Pharmaceuticals Inc. |
Morphinan compounds
|
WO2010036773A1
(fr)
*
|
2008-09-24 |
2010-04-01 |
Concert Pharmaceuticals, Inc. |
Dérivés déutérisés de l-aryl-2-aminométhylcyclopropane carboxamide
|
WO2010036796A1
(fr)
*
|
2008-09-26 |
2010-04-01 |
Concert Pharmaceuticals, Inc. |
Dérivés de pyridine amine
|
US20100113606A1
(en)
*
|
2008-11-05 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
Aminopropanol modulators of beta-1 adrenergic receptor
|
US20100113431A1
(en)
*
|
2008-11-05 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
N-methyl piperazine modulators of h1 receptor
|
US8227451B2
(en)
|
2008-11-12 |
2012-07-24 |
Auspex Pharmaceuticals |
Phenylacetic acid inhibitors of cyclooxygenase
|
US9045453B2
(en)
|
2008-11-14 |
2015-06-02 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
US20100137215A1
(en)
*
|
2008-11-25 |
2010-06-03 |
Concert Pharmaceuticals Inc. |
Novel tetrahydro-1h-pyrido[4,3-b]indoles
|
MX2011006094A
(es)
|
2008-12-08 |
2011-11-29 |
Gilead Connecticut Inc |
Inhibidores de imidazopirazina syk.
|
PT2373169E
(pt)
|
2008-12-08 |
2015-10-05 |
Gilead Connecticut Inc |
Inibidores de imidazopirazina da syk
|
US8450321B2
(en)
|
2008-12-08 |
2013-05-28 |
Gilead Connecticut, Inc. |
6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
|
HU230067B1
(hu)
|
2008-12-17 |
2015-06-29 |
Richter Gedeon Nyrt |
Új piperazin só és eljárás előállítására
|
HUP0800766A2
(en)
|
2008-12-18 |
2010-11-29 |
Richter Gedeon Vegyeszet |
Process for the preparation of piperazine derivatives
|
HUP0800765A2
(en)
|
2008-12-18 |
2010-11-29 |
Richter Gedeon Nyrt |
A new process for the preparation of piperazine derivatives and their hydrochloric salts
|
US8263601B2
(en)
|
2009-02-27 |
2012-09-11 |
Concert Pharmaceuticals, Inc. |
Deuterium substituted xanthine derivatives
|
US20110053961A1
(en)
*
|
2009-02-27 |
2011-03-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
US8563554B2
(en)
|
2009-03-17 |
2013-10-22 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
WO2010118291A2
(fr)
|
2009-04-10 |
2010-10-14 |
Auspex Pharmaceuticals, Inc. |
Modulateurs à base d'acide biphényl-3-carboxylique du béta-3-adrénorécepteur
|
EP3026052A1
(fr)
|
2009-04-20 |
2016-06-01 |
Auspex Pharmaceuticals, Inc. |
Preparation des inhibiteurs pipéridiniques deuteriés de la janus kinase3
|
EP2421808B1
(fr)
|
2009-04-23 |
2013-07-31 |
Concert Pharmaceuticals Inc. |
Analogues de l'acide 4-hydroxybutyrique
|
WO2010127272A2
(fr)
*
|
2009-04-30 |
2010-11-04 |
Concert Pharmaceuticals, Inc. |
Dérivés hydroxyéthylamino sulfonamides
|
US20120058085A1
(en)
*
|
2009-05-15 |
2012-03-08 |
Persichetti Rose A |
Deuterium Modified Benzimidazoles
|
WO2010135579A1
(fr)
|
2009-05-22 |
2010-11-25 |
Concert Pharmaceuticals, Inc. |
Dérivés fluorés de diaryl urée
|
US20120244122A1
(en)
*
|
2009-05-28 |
2012-09-27 |
Masse Craig E |
Peptides for the Treatment of HCV Infections
|
US20110053968A1
(en)
|
2009-06-09 |
2011-03-03 |
Auspex Pharmaceuticals, Inc. |
Aminopyrimidine inhibitors of tyrosine kinase
|
WO2010147830A2
(fr)
|
2009-06-15 |
2010-12-23 |
Auspex Pharmaceuticals, Inc. |
Modulateurs aminothiazole de bêta-3-adrénorécepteur
|
ES2469849T3
(es)
|
2009-06-18 |
2014-06-20 |
Concert Pharmaceuticals Inc. |
Derivados deuterados de isoindolin-1,3-diona como inhibidores de PDE4 y TNF-alfa
|
JP2012531419A
(ja)
|
2009-06-23 |
2012-12-10 |
コンサート ファーマシューティカルズ インコーポレイテッド |
Gaba−a受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体
|
WO2011009075A2
(fr)
*
|
2009-07-17 |
2011-01-20 |
Rigel Pharmaceuticals, Inc. |
Composés 2,4-pyrimidine diamine deutérés et leurs promédicaments et leurs utilisations
|
JP2013500347A
(ja)
*
|
2009-07-27 |
2013-01-07 |
オースペックス ファーマシューティカルズ,インク. |
P2y12受容体のシクロプロピルモジュレーター
|
US9512104B2
(en)
|
2009-07-28 |
2016-12-06 |
Auspex Pharmaceuticals, Inc. |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
US8637524B2
(en)
|
2009-07-28 |
2014-01-28 |
Auspex Pharmaceuticals, Inc |
Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2
|
US8575348B2
(en)
|
2009-07-28 |
2013-11-05 |
Auspex Pharmaceuticals, Inc |
Quinolone inhibitors of lipoprotein-associated phospholipase A2
|
DK2921486T3
(da)
*
|
2009-08-07 |
2017-11-13 |
American Life Science Pharmaceuticals Inc |
Sammensætninger og fremgangsmåder til behandling af beta-amyloid-relaterede sygdomme
|
US20110105603A1
(en)
*
|
2010-08-06 |
2011-05-05 |
American Life Science Pharmaceuticals, Inc. |
Compositions and methods for treating beta-amyloid related diseases
|
US8530479B2
(en)
*
|
2009-08-10 |
2013-09-10 |
Daljit Singh Dhanoa |
Deuterium-enriched alkyl sulfonamides
|
WO2011020044A1
(fr)
|
2009-08-14 |
2011-02-17 |
Concert Pharmaceuticals, Inc. |
Dérivés de triazolophtalazine substituée
|
US8658236B2
(en)
|
2009-08-21 |
2014-02-25 |
Deuteria Beverages, Llc |
Alcoholic compositions having a lowered risk of acetaldehydemia
|
EP2473052A4
(fr)
|
2009-09-02 |
2013-03-20 |
Concert Pharmaceuticals Inc |
Dérivés de xanthine substitués
|
US9260432B2
(en)
|
2009-09-02 |
2016-02-16 |
Concert Pharmaceuticals, Inc. |
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
|
CN101666757B
(zh)
*
|
2009-09-25 |
2011-03-16 |
广东省药品检验所 |
中草药降压产品中掺杂二氢吡啶类降压化合物的快筛方法
|
RU2012117395A
(ru)
*
|
2009-09-28 |
2013-11-10 |
Ф.Хоффманн-Ля Рош Лтд |
Новые макроциклические ингибиторы репликации вируса гепатита с
|
WO2011047315A1
(fr)
|
2009-10-15 |
2011-04-21 |
Concert Pharmaceuticals, Inc. |
Benzimidazoles substitués
|
US9260424B2
(en)
|
2009-10-26 |
2016-02-16 |
Auspex Pharmaceuticals, Inc. |
4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
|
WO2011056647A1
(fr)
*
|
2009-10-28 |
2011-05-12 |
Anadys Pharmaceuticals, Inc. |
Composés 5,6-dihydro-1h-pyridine-2-un deutérés
|
AU2010314593B2
(en)
*
|
2009-11-04 |
2015-05-21 |
Sichuan Beilike Biotechnology Limited Liability Company |
Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof
|
WO2011056764A1
(fr)
*
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Imidazo[2,1-b][1,3]benzothiazoles enrichis en isotopes ou fluores
|
WO2011063001A1
(fr)
*
|
2009-11-18 |
2011-05-26 |
Concert Pharmaceuticals, Inc. |
Promédicaments de niacine et versions deutérisées de ceux-ci
|
US20110152303A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Glaxosmithkline Llc |
Chemical Compounds
|
CN102203112B
(zh)
|
2010-01-15 |
2014-05-07 |
苏州润新生物科技有限公司 |
某些化合物、组合物及方法
|
WO2011103457A1
(fr)
*
|
2010-02-18 |
2011-08-25 |
Concert Pharmaceuticals Inc. |
Dérivés de la pyrimidine
|
EP2542534A1
(fr)
|
2010-03-02 |
2013-01-09 |
Concert Pharmaceuticals Inc. |
Dérivés de tétrahydronaphtalène deutérés
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
JP5938352B2
(ja)
|
2010-03-11 |
2016-06-22 |
ギリアード コネチカット, インコーポレイテッド |
イミダゾピリジンsyk阻害剤
|
US8575221B2
(en)
|
2010-03-17 |
2013-11-05 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
EP2560488B1
(fr)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Aminopyridines et aminotriazines, leurs compositions et leurs procédés d'utilisation
|
EP2576552A4
(fr)
*
|
2010-06-01 |
2013-11-13 |
Aupex Pharmaceutical Inc |
Inhibiteurs benzoquinolone de vmat2
|
WO2012006070A1
(fr)
*
|
2010-06-28 |
2012-01-12 |
Vertex Pharmaceuticals Incorporated |
Composés et méthodes de traitement ou de prévention d'infections à flavivirus
|
GB2496794B
(en)
|
2010-07-15 |
2017-11-01 |
Iliich Epshtein Oleg |
Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
|
CZ2013105A3
(cs)
|
2010-07-15 |
2013-05-22 |
Iliich Epshtein@Oleg |
Zpusob zvýsení úcinku aktivované potencované formy protilátky
|
FR2962652A1
(fr)
|
2010-07-15 |
2012-01-20 |
Oleg Iliich Epshtein |
Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees a des maladies neurodegeneratives
|
WO2012009446A1
(fr)
|
2010-07-16 |
2012-01-19 |
Concert Pharmaceuticals Inc. |
Nouveaux dérivés pyrimidinecarboxamide
|
NZ606970A
(en)
|
2010-07-21 |
2015-08-28 |
Oleg Iliich Epshtein |
A method of treating attention deficit hyperactivity disorder
|
CA2808359C
(fr)
|
2010-08-23 |
2019-09-24 |
Suzhou Neupharma Co., Ltd. |
Analogues de celasterol et compositions pharmaceutiques en renfermant
|
CN102656179B
(zh)
|
2010-08-28 |
2015-07-29 |
苏州润新生物科技有限公司 |
蟾蜍灵衍生物、其药物组合物及用途
|
WO2012031073A1
(fr)
|
2010-09-01 |
2012-03-08 |
Concert Pharmaceuticals, Inc. |
Procédé de préparation d'un alcool secondaire deutéré à enrichissement énantiomérique à partir d'une cétone correspondante sans réduction de l'intégration de deutérium
|
US9085788B2
(en)
|
2010-09-01 |
2015-07-21 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
CN103327972A
(zh)
|
2010-10-11 |
2013-09-25 |
里兰斯坦福初级大学理事会 |
取代的苯甲酰胺及其用途
|
WO2012088445A1
(fr)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Conjugués promédicaments polymères à plusieurs bras de composés à base de cabazitaxel
|
US20130331443A1
(en)
|
2010-12-22 |
2013-12-12 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
WO2012103810A1
(fr)
|
2011-02-02 |
2012-08-09 |
Suzhou Neupharma Co., Ltd |
Certaines entités chimiques, compositions et procédés
|
US8759394B2
(en)
|
2011-02-14 |
2014-06-24 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
US9145390B2
(en)
|
2011-03-03 |
2015-09-29 |
Concert Pharmaceuticals, Inc. |
Derivatives of pyrazole-substituted amino-heteroaryl compounds
|
US8889687B2
(en)
|
2011-03-04 |
2014-11-18 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
CN103561741A
(zh)
|
2011-03-08 |
2014-02-05 |
奥斯拜客斯制药有限公司 |
取代的n-芳基吡啶酮
|
US9090585B2
(en)
|
2011-03-28 |
2015-07-28 |
Deuterx, Llc |
2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds
|
DK2705013T3
(en)
*
|
2011-05-04 |
2016-07-18 |
Balance Therapeutics Inc |
Pentylenetetrazolderivater
|
EP2709986B1
(fr)
*
|
2011-05-18 |
2017-03-22 |
Concert Pharmaceuticals Inc. |
Dérivés deutérés de l'ivacaftor
|
HUE047354T2
(hu)
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
US8691808B2
(en)
|
2011-05-20 |
2014-04-08 |
Influmedix, Inc. |
Antiviral compounds and their methods of use
|
SG194625A1
(en)
*
|
2011-05-23 |
2013-12-30 |
Sanofi Sa |
Process for the preparation of deuterated compounds containing n-alkyl groups
|
US8778223B2
(en)
|
2011-05-24 |
2014-07-15 |
Lc Vision, Llc |
Liquid crystals having cyclohexyl core structures and fluorinated tails
|
MX361020B
(es)
|
2011-06-17 |
2018-11-26 |
Pfizer Anti Infectives Ab |
Procesos para preparar compuestos heterociclicos, incluida trans-7-oxo-6-(sulfooxi)-1,6-diazabiciclo [3,2,1]octano-2-carboxam ida y sales de la misma.
|
PL2720989T3
(pl)
|
2011-06-20 |
2017-05-31 |
H. Lundbeck A/S |
Deuterowane 1-piperazyno-3-fenyloindany do leczenia schizofrenii
|
CN107245056A
(zh)
|
2011-08-26 |
2017-10-13 |
润新生物公司 |
化学实体、组合物及方法
|
EP2753174A4
(fr)
|
2011-09-01 |
2015-05-20 |
Xiangping Qian |
Entités chimiques particulières, compositions et méthodes
|
CN115403531A
(zh)
|
2011-09-14 |
2022-11-29 |
润新生物公司 |
作为激酶抑制剂的化学实体、组合物及方法
|
EP2757885B1
(fr)
|
2011-09-21 |
2017-03-15 |
Neupharma, Inc. |
Entités chimiques, compositions, et procédés spécifiques
|
WO2013049701A1
(fr)
|
2011-09-30 |
2013-04-04 |
Neupharma, Inc. |
Certaines entités chimiques, compositions et procédés
|
IN2014CN04470A
(fr)
|
2011-11-18 |
2015-09-04 |
Codexis Inc |
|
RU2019104004A
(ru)
|
2012-01-23 |
2019-03-07 |
Сейдж Терапьютикс, Инк. |
Лекарственные формы нейроактивных стероидов и способы лечения нарушений цнс
|
EP2806874B1
(fr)
|
2012-01-25 |
2017-11-15 |
Neupharma, Inc. |
Dérivés de quinoxaline-oxy-phenyl comme inhibiteurs de kinases
|
WO2013132263A1
(fr)
*
|
2012-03-09 |
2013-09-12 |
Axelar Ab |
Dérivés de picropodophylline pour utilisation en thérapie
|
US9822058B2
(en)
|
2012-04-05 |
2017-11-21 |
Chdi Foundation, Inc. |
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
WO2013155338A2
(fr)
|
2012-04-12 |
2013-10-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Benzamides substituées et leurs utilisations
|
IN2014DN08443A
(fr)
|
2012-04-13 |
2015-05-08 |
Concert Pharmaceuticals Inc |
|
WO2013159026A1
(fr)
|
2012-04-20 |
2013-10-24 |
Concert Pharmaceuticals, Inc. |
Rigosertib deutéré
|
EP3453713B1
(fr)
|
2012-04-29 |
2021-09-08 |
Neupharma, Inc. |
Dérivés bufadiènolides substitués en position 3 par un groupement amine pour le traitement du cancer
|
US20150197525A1
(en)
|
2012-06-15 |
2015-07-16 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of ruxolitinib
|
CN102757417B
(zh)
*
|
2012-06-18 |
2014-09-24 |
中国科学院广州生物医药与健康研究院 |
氘代苯并吡喃类化合物及其应用
|
WO2014008417A1
(fr)
|
2012-07-04 |
2014-01-09 |
Concert Pharmaceuticals, Inc. |
Vercirnon deutéré
|
CA2908929C
(fr)
|
2012-07-12 |
2021-01-26 |
Concert Pharmaceuticals, Inc. |
Idebenone deuteree
|
CA2879400A1
(fr)
|
2012-07-30 |
2014-02-06 |
Concert Pharmaceuticals, Inc. |
Ibrutinib deutere
|
GB201214169D0
(en)
*
|
2012-08-08 |
2012-09-19 |
Biostatus Ltd |
New compounds and uses thereof
|
ES2717279T3
(es)
|
2012-08-17 |
2019-06-20 |
Concert Pharmaceuticals Inc |
Baricitinib deuterada
|
WO2014031732A2
(fr)
|
2012-08-22 |
2014-02-27 |
Cornell University |
Méthodes d'inhibition de la fascine
|
US9550780B2
(en)
|
2012-09-18 |
2017-01-24 |
Auspex Pharmaceuticals, Inc. |
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
|
AU2013318182C1
(en)
|
2012-09-18 |
2022-01-20 |
Auspex Pharmaceuticals, Inc. |
Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
|
US9688635B2
(en)
|
2012-09-24 |
2017-06-27 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
US9643950B2
(en)
|
2012-10-22 |
2017-05-09 |
Concert Pharmaceuticals, Inc. |
Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione}
|
EP2916838B1
(fr)
|
2012-11-12 |
2019-03-13 |
Neupharma, Inc. |
Certaines entités chimiques, compositions et certains procédés
|
JP6146990B2
(ja)
*
|
2012-11-16 |
2017-06-14 |
コンサート ファーマシューティカルズ インコーポレイテッド |
重水素化されたcftr増強物質
|
CN109364075B
(zh)
*
|
2012-11-21 |
2021-10-29 |
顶点制药(欧洲)有限公司 |
氘化cftr增效剂
|
US20150299166A1
(en)
*
|
2012-12-20 |
2015-10-22 |
Concert Pharmaceuticals, Inc. |
Deuterated alk inhibitors
|
EP2943489B1
(fr)
|
2013-01-09 |
2018-04-11 |
Concert Pharmaceuticals Inc. |
Momélotinib deutéré
|
JP6359563B2
(ja)
|
2013-01-14 |
2018-07-18 |
デュートルクス・リミテッド・ライアビリティ・カンパニーDeuteRx, LLC |
3−(5置換−4−オキソキナゾリン−3(4h)−イル)−3−ジュウテロピペリジン−2,6−ジオン誘導体
|
EP3421469A1
(fr)
*
|
2013-01-31 |
2019-01-02 |
Auspex Pharmaceuticals, Inc. |
Inhibiteurs benzoquinolone de vmat2
|
GB201302368D0
(en)
*
|
2013-02-11 |
2013-03-27 |
Univ Bath |
Compound
|
CA2941560A1
(fr)
|
2013-03-14 |
2014-09-25 |
Deuterx, Llc |
Derives de 3-(oxoquinazolin-3(4h)-yl-4 substitue)-3-deutero-piperidine-2,6-dione et des compositions les comprenant et des procedes les utilisant
|
AU2014236510A1
(en)
|
2013-03-14 |
2015-09-24 |
Deuterx, Llc |
Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
|
US9713330B1
(en)
|
2013-03-15 |
2017-07-25 |
Deuteria Agrochemicals, Llc |
Deuterium-enriched aldehydes
|
EP2968268B1
(fr)
|
2013-03-15 |
2020-07-29 |
Concert Pharmaceuticals Inc. |
Inhibiteurs de l'enzyme udp-glucose : n-acyl-sphingosine glucosyltransférase
|
BR112015023392A2
(pt)
|
2013-03-15 |
2017-07-18 |
Deuteria Agrochemicals Llc |
composição e método de modulação do comportamento de insetos
|
CN104109149B
(zh)
|
2013-04-22 |
2018-09-28 |
苏州泽璟生物制药有限公司 |
氘代的二氨基嘧啶化合物以及包含该化合物的药物组合物
|
PT3027618T
(pt)
|
2013-07-30 |
2020-10-12 |
Kronos Bio Inc |
Polimorfo de inibidores de syk
|
AP2016009007A0
(en)
|
2013-07-30 |
2016-01-31 |
Gilead Connecticut Inc |
Formulation of syk inhibitors
|
PH12019500143A1
(en)
|
2013-08-23 |
2020-03-02 |
Neupharma Inc |
Certain chemical entities, compositions, and methods
|
WO2015031741A1
(fr)
|
2013-08-30 |
2015-03-05 |
Concert Pharmaceuticals, Inc. |
Thiénotriazolodiazépines substituées
|
KR102495941B1
(ko)
|
2013-12-03 |
2023-02-06 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
NZ720301A
(en)
|
2013-12-03 |
2022-01-28 |
Auspex Pharmaceuticals Inc |
Deuterated tetrabenazine compounds
|
WO2015084992A1
(fr)
|
2013-12-04 |
2015-06-11 |
Gilead Sciences, Inc. |
Procédés pour le traitement de cancers
|
US9732031B2
(en)
|
2013-12-20 |
2017-08-15 |
Deuterx, Llc |
Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion
|
US9290505B2
(en)
|
2013-12-23 |
2016-03-22 |
Gilead Sciences, Inc. |
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
|
TWI662037B
(zh)
|
2013-12-23 |
2019-06-11 |
美商基利科學股份有限公司 |
脾酪胺酸激酶抑制劑
|
US9611252B2
(en)
|
2013-12-30 |
2017-04-04 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
KR20160106627A
(ko)
|
2013-12-30 |
2016-09-12 |
라이프에스씨아이 파마슈티컬스, 인크. |
치료적 억제 화합물
|
US10188639B2
(en)
|
2014-01-15 |
2019-01-29 |
Deuterx, Llc |
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
|
CN106459056A
(zh)
|
2014-02-10 |
2017-02-22 |
康塞特医药品公司 |
经取代的三唑苯二氮卓
|
JP6691869B2
(ja)
|
2014-02-20 |
2020-05-13 |
コーネル ユニヴァーシティー |
ファシンを阻害するための化合物及び方法
|
WO2015154025A1
(fr)
*
|
2014-04-04 |
2015-10-08 |
Intra-Cellular Therapies, Inc. |
Composés organiques
|
DK3157926T3
(da)
*
|
2014-06-20 |
2019-08-19 |
Intra Cellular Therapies Inc |
Organiske forbindelser
|
NZ726365A
(en)
|
2014-07-14 |
2018-06-29 |
Gilead Sciences Inc |
Combinations for treating cancers
|
EA037299B1
(ru)
|
2014-09-17 |
2021-03-05 |
Селджен Кар Ллс |
Ингибиторы mk2 и их применения
|
WO2016069630A1
(fr)
|
2014-10-27 |
2016-05-06 |
Concert Pharmaceuticals, Inc. |
Esters d'acide phosphonique de pyrimidine portant au moins un atome de deutérium
|
JP2017533911A
(ja)
*
|
2014-10-29 |
2017-11-16 |
センター ラボラトリーズ, インク.Center Laboratories, Inc. |
ベラパミル塩酸塩の結晶型
|
JP2017533923A
(ja)
|
2014-11-06 |
2017-11-16 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
Fxr/tgr5アゴニストとしての胆汁酸類似体およびその使用方法
|
WO2016086115A1
(fr)
|
2014-11-26 |
2016-06-02 |
Enanta Pharmaceuticals, Inc. |
Dérivés de tétrazole d'acides biliaires utilisés en tant qu'agonistes de fxr/tgr5 et leurs procédés d'utilisation
|
US10208081B2
(en)
|
2014-11-26 |
2019-02-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
US20160214918A1
(en)
*
|
2015-01-22 |
2016-07-28 |
Kaohsiung Medical University |
Composition for treating metabolic syndrome and a preparation method thereof
|
CN105985396A
(zh)
*
|
2015-02-16 |
2016-10-05 |
苏州泽璟生物制药有限公司 |
氘代鹅去氧胆酸衍生物以及包含该化合物的药物组合物
|
WO2016133935A1
(fr)
|
2015-02-17 |
2016-08-25 |
Neupharma, Inc. |
Entités chimiques, compositions et méthodes particulières
|
KR20230003264A
(ko)
|
2015-03-06 |
2023-01-05 |
오스펙스 파마슈티칼스, 인코포레이티드 |
비정상적 불수의 운동 장애의 치료 방법
|
CN107427527B
(zh)
|
2015-03-31 |
2021-01-26 |
英安塔制药有限公司 |
作为fxr/tgr5激动剂的胆汁酸衍生物及其使用方法
|
CA2981495C
(fr)
|
2015-03-31 |
2023-09-26 |
Vertex Pharmaceuticals (Europe) Limited |
Vx-661 deutere
|
US20180311258A1
(en)
*
|
2015-04-10 |
2018-11-01 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
US10683305B2
(en)
|
2015-04-27 |
2020-06-16 |
Concert Pharmaceuticals, Inc. |
Deuterated OTX-015
|
CN106279039B
(zh)
*
|
2015-06-02 |
2019-01-11 |
青岛海洋生物医药研究院股份有限公司 |
氘代脱氢苯基阿夕斯丁类化合物及其制备方法和在制备抗肿瘤的药物中的应用
|
WO2017001926A2
(fr)
|
2015-07-01 |
2017-01-05 |
Lifesci Pharmaceuticals, Inc |
Composés inhibiteurs thérapeutiques
|
US9809603B1
(en)
|
2015-08-18 |
2017-11-07 |
Deuterx, Llc |
Deuterium-enriched isoindolinonyl-piperidinonyl conjugates and oxoquinazolin-3(4H)-yl-piperidinonyl conjugates and methods of treating medical disorders using same
|
MA42954A
(fr)
|
2015-09-25 |
2018-08-01 |
Vertex Pharmaceuticals Europe Ltd |
Potentialisateurs cftr deutérés
|
EP3374350B1
(fr)
|
2015-11-09 |
2022-01-05 |
Forge Therapeutics, Inc. |
Composés à base d'hydroxypyridinone et d'hydroxypyrimidinone pour le traitement d'infections bactériennes
|
US11267777B2
(en)
|
2015-11-19 |
2022-03-08 |
Concert Pharmaceuticals, Inc. |
Deuterated EPI-743
|
EP3386536A4
(fr)
|
2015-12-07 |
2019-07-31 |
Opi Vi- IP Holdco LLC |
Composition de conjugués d'agonistes-constructions d'anticorps et leurs procédés d'utilisation
|
CN106892924B
(zh)
*
|
2015-12-17 |
2021-01-08 |
四川科伦博泰生物医药股份有限公司 |
短效苯并二氮*衍生物、其制备方法及其用途
|
EP3416629A4
(fr)
|
2016-02-16 |
2019-08-07 |
CoNCERT Pharmaceuticals, Inc. |
Gft-505 deutéré
|
US10364267B2
(en)
*
|
2016-02-23 |
2019-07-30 |
Enanta Pharmaceuticals, Inc. |
Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
EP3398942B1
(fr)
|
2016-02-25 |
2021-01-27 |
Shenzhen TargetRx, Inc. |
Composé chimique d'oxadiazole substitué et composition contenant ledit composé chimique, et utilisation associée
|
MA43815A
(fr)
|
2016-03-08 |
2021-04-07 |
Sage Therapeutics Inc |
Stéroïdes neuroactifs, compositions, et leurs utilisations
|
DK3407889T3
(da)
|
2016-03-25 |
2021-08-09 |
Intra Cellular Therapies Inc |
Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet
|
US11274087B2
(en)
|
2016-07-08 |
2022-03-15 |
Richter Gedeon Nyrt. |
Industrial process for the preparation of cariprazine
|
WO2018011628A1
(fr)
|
2016-07-11 |
2018-01-18 |
Lifesci Pharmaceuticals, Inc. |
Composés inhibiteurs thérapeutiques
|
CA3033370A1
(fr)
|
2016-08-15 |
2018-02-22 |
Neupharma, Inc. |
Entites chimiques, compositions et methodes particulieres
|
US10912769B2
(en)
*
|
2016-09-29 |
2021-02-09 |
Jiangsu Jibeier Pharmaceutical Co. Ltd. |
1-[(pyridin-3-yl-sulfonyl)-1H-pyrrol-3-yl] methanamine derivative and pharmaceutical composition and use thereof
|
US11331316B2
(en)
|
2016-10-12 |
2022-05-17 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
JP2017105824A
(ja)
*
|
2017-02-10 |
2017-06-15 |
コンサート ファーマシューティカルズ インコーポレイテッド |
重水素化されたcftr増強物質
|
SG10202110184XA
(en)
|
2017-03-15 |
2021-10-28 |
Silverback Therapeutics Inc |
Benzazepine compounds, conjugates, and uses thereof
|
US11230551B2
(en)
|
2017-03-16 |
2022-01-25 |
Celgene Car Llc |
Deuterated analogs of MK2 inhibitors and uses thereof
|
US11124525B2
(en)
|
2017-03-16 |
2021-09-21 |
Celgene Car Llc |
Heteroaryl compounds useful as MK2 inhibitors
|
EP3596084A4
(fr)
|
2017-03-16 |
2020-12-23 |
Celgene CAR LLC |
Composés 9,10,11,12-tétrahydro-8h-[1,4]diazépino[5',6':4,5]thiéno[3,2-f]quinolin-8-one et leurs utilisations
|
WO2018175969A1
(fr)
|
2017-03-24 |
2018-09-27 |
Intra-Cellular Therapies, Inc. |
Nouvelles compositions et méthodes
|
WO2018208985A2
(fr)
|
2017-05-10 |
2018-11-15 |
Forge Therapeutics, Inc. |
Composés antibactériens
|
BR112019025420A2
(pt)
|
2017-06-01 |
2020-06-16 |
Xoc Pharmaceuticals, Inc. |
Compostos policíclicos e usos destes
|
CN107226769A
(zh)
*
|
2017-06-19 |
2017-10-03 |
郑州泰基鸿诺医药股份有限公司 |
一种含二氟氘代甲氧(硫)基官能团的芳香类化合物的合成方法
|
CN109422731A
(zh)
*
|
2017-08-24 |
2019-03-05 |
正大天晴药业集团股份有限公司 |
氘代喹啉衍生物
|
CN115028640A
(zh)
|
2017-08-25 |
2022-09-09 |
吉利德科学公司 |
Syk抑制剂的多晶型物
|
EP3653622B1
(fr)
*
|
2017-08-30 |
2022-12-28 |
Shenzhen TargetRx, Inc. |
Composé aminopyrimidine, composition le comprenant et utilisation associée
|
WO2019084060A1
(fr)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
Conjugués et leurs procédés d'utilisation pour l'administration sélective d'agents immunomodulateurs
|
US20230192625A1
(en)
*
|
2017-11-14 |
2023-06-22 |
Shenzhen Targetrx, Inc. |
Substituted benzimidazole compound and composition comprising same
|
BR112020010156A2
(pt)
|
2017-11-22 |
2020-11-10 |
Concert Pharmaceuticals, Inc. |
análogos deuterados de d-serina e usos dos mesmos
|
BR112020010335A2
(pt)
|
2017-12-01 |
2020-11-10 |
Vertex Pharmaceuticals Incorporated |
processos para produzir moduladores de regulador de condutância de transmembrana de fibrose cística
|
US20200291059A1
(en)
|
2017-12-08 |
2020-09-17 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
TWI780281B
(zh)
*
|
2017-12-14 |
2022-10-11 |
丹麥商Nmd藥品公司 |
用於治療神經肌肉病症的化合物
|
AU2018385693A1
(en)
|
2017-12-15 |
2020-06-18 |
Silverback Therapeutics, Inc. |
Antibody construct-drug conjugate for the treatment of hepatitis
|
WO2019120194A1
(fr)
*
|
2017-12-22 |
2019-06-27 |
深圳市塔吉瑞生物医药有限公司 |
Composé pyrazolo[1,5-a]pyrimidine substitué, composition pharmaceutique et utilisation associée
|
MA51620A
(fr)
|
2018-01-19 |
2020-11-25 |
Cytokinetics Inc |
Analogues de dihydrobenzofurane et d'inden en tant qu'inhibiteurs de sarcomes cardiaques
|
WO2019144885A1
(fr)
|
2018-01-23 |
2019-08-01 |
深圳市塔吉瑞生物医药有限公司 |
Composé macrocyclique de pyrazolo [1,5-a]pyrimidine substitué
|
WO2019152883A1
(fr)
|
2018-02-02 |
2019-08-08 |
Padforward Llc |
Inhibiteurs de protéine arginine déiminases
|
SG11202007492XA
(en)
|
2018-02-08 |
2020-09-29 |
Neupharma Inc |
Certain chemical entities, compositions, and methods
|
BR112020018669A2
(pt)
*
|
2018-03-21 |
2020-12-29 |
Izumi Technology, Llc |
Análogos deuterados de elacridar
|
WO2019195278A1
(fr)
|
2018-04-02 |
2019-10-10 |
Silverback Therapeutics, Inc. |
Inhibiteurs d'alk5, conjugués et leurs utilisations
|
US11447493B2
(en)
|
2018-05-02 |
2022-09-20 |
Kinnate Biopharma Inc. |
Inhibitors of cyclin-dependent kinases
|
EP3802518A1
(fr)
|
2018-05-25 |
2021-04-14 |
Silverback Therapeutics, Inc. |
Composés d'amino-pyrazinecarboxamide, conjugués et leurs utilisations
|
WO2020005887A1
(fr)
|
2018-06-26 |
2020-01-02 |
Cytokinetics, Inc. |
Inhibiteurs de sarcomères cardiaques
|
EP3814343B1
(fr)
|
2018-06-26 |
2023-01-11 |
Cytokinetics, Inc. |
Inhibiteurs de sarcomères cardiaques
|
TW202016094A
(zh)
|
2018-06-29 |
2020-05-01 |
美商奇奈特生物製藥公司 |
週期素依賴性激酶抑制劑
|
JP6654223B2
(ja)
*
|
2018-08-13 |
2020-02-26 |
バーテックス ファーマシューティカルズ (ヨーロッパ) リミテッド |
重水素化されたcftr増強物質
|
CN109020875B
(zh)
*
|
2018-08-27 |
2020-05-22 |
北京市药品检验所 |
二氢吡啶类化合物脱氢芳构化方法及在药品检测中的用途
|
EP3843739A4
(fr)
|
2018-08-31 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
Nouvelles méthodes
|
TW202023648A
(zh)
|
2018-08-31 |
2020-07-01 |
美商胞質動力學公司 |
心臟肌小節抑制劑
|
EP3843738A4
(fr)
|
2018-08-31 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
Nouvelles méthodes
|
AU2019334994A1
(en)
*
|
2018-09-05 |
2021-04-08 |
Lupin Inc. |
Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof
|
US20200113912A1
(en)
|
2018-09-12 |
2020-04-16 |
Silverback Therapeutics, Inc. |
Methods and Compositions for the Treatment of Disease with Immune Stimulatory Conjugates
|
WO2020056194A1
(fr)
|
2018-09-12 |
2020-03-19 |
Silverback Therapeutics, Inc. |
Composés de benzazépine, conjugués et utilisations associées
|
CA3112545A1
(fr)
|
2018-09-12 |
2020-03-19 |
Silverback Therapeutics, Inc. |
Composes de benzazepine substitues, conjugues et leurs utilisations
|
SG11202102712WA
(en)
|
2018-09-20 |
2021-04-29 |
Forge Therapeutics Inc |
Antibacterial compounds
|
JP2022514114A
(ja)
|
2018-10-16 |
2022-02-09 |
ジーエルオー ファーマ,インク. |
ニコチン性アセチルコリン受容体ペプチドアンタゴニストであるコノトキシン組成物、およびこれに関連する方法
|
WO2020097265A1
(fr)
|
2018-11-06 |
2020-05-14 |
Edgewise Therapeutics, Inc. |
Composés de pyridazinone et utilisations associées
|
CA3118904A1
(fr)
|
2018-11-06 |
2020-05-14 |
Edgewise Therapeutics, Inc. |
Composes de pyridazinone et leurs utilisations
|
HRP20231389T1
(hr)
|
2018-11-06 |
2024-03-01 |
Edgewise Therapeutics, Inc. |
Spojevi piridazinona i njihove upotrebe
|
JP2022509965A
(ja)
|
2018-12-03 |
2022-01-25 |
ハー・ルンドベック・アクチエゼルスカベット |
4-((1R,3S)-6-クロロ-3-フェニル-2,3-ジヒドロ-1H-インデン-1-イル)-1,2,2-トリメチルピペラジン及び4-((1R,3S)-6-クロロ-3-(フェニル-d5)-2,3-ジヒドロ-1H-インデン-1-イル)-2,2-ジメチル-1-(メチル-d3)ピペラジンのプロドラッグ
|
AR117228A1
(es)
*
|
2018-12-06 |
2021-07-21 |
Arisan Therapeutics |
DERIVADOS DE PIRAZOLO[1,2-a]PIRIDINA, 1H-BENZO[d][1,2,3]TRIAZOL, IMIDAZOPIRIMIDINA Y BENCIMIDAZOL PARA USAR EN EL TRATAMIENTO DE LA INFECCIÓN POR ARENAVIRUS
|
WO2020115715A1
(fr)
*
|
2018-12-06 |
2020-06-11 |
Intrabio Ltd. |
Analogues deutérés d'acétyl-leucine
|
BR112021014479A2
(pt)
|
2019-01-22 |
2021-10-13 |
Aeovian Pharmaceuticals, Inc. |
Moduladores de mtorc e seus usos
|
KR20210132104A
(ko)
|
2019-02-19 |
2021-11-03 |
울티마 제노믹스, 인크. |
광학 검출 및 시퀀싱을 위한 링커 및 방법
|
KR20210131372A
(ko)
|
2019-02-22 |
2021-11-02 |
크로노스 바이오, 인코포레이티드 |
Syk 억제제로서의 축합된 피라진의 고체 형태
|
CA3131104A1
(fr)
|
2019-03-06 |
2020-09-10 |
Silverback Therapeutics, Inc. |
Composes cycliques d'amino-pyrazinecarboxamide et leurs utilisations
|
US11547707B2
(en)
|
2019-04-10 |
2023-01-10 |
Richter Gedeon Nyrt. |
Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
|
EP3955926A4
(fr)
|
2019-04-18 |
2022-11-30 |
Azura Ophthalmics Ltd. |
Composés et procédés pour le traitement de troubles oculaires
|
WO2020212760A2
(fr)
|
2019-04-18 |
2020-10-22 |
Azura Ophthalmics Ltd. |
Composés et procédés pour le traitement de troubles oculaires
|
EP3962484A4
(fr)
|
2019-05-03 |
2023-01-18 |
Kinnate Biopharma Inc. |
Inhibiteurs de kinases raf
|
WO2020226628A1
(fr)
|
2019-05-07 |
2020-11-12 |
Nirsum Laboratories, Inc. |
Promédicaments antagonistes du récepteur opioïde pour le traitement de la dépendance aux opioïdes
|
WO2020247540A1
(fr)
|
2019-06-03 |
2020-12-10 |
Biointervene, Inc. |
Analogues d'adénosine pour le traitement d'une maladie
|
WO2020247546A1
(fr)
|
2019-06-03 |
2020-12-10 |
Biointervene, Inc. |
Analogues d'adénosine pour le traitement d'une maladie
|
US20220387400A1
(en)
|
2019-07-08 |
2022-12-08 |
Belite Bio, Llc |
Formulations of rbp4 inhibitors and methods of use
|
EP3999501A1
(fr)
|
2019-07-16 |
2022-05-25 |
Silverback Therapeutics, Inc. |
Inhibiteurs d'alk5, conjugués et leurs utilisations
|
WO2021055376A1
(fr)
|
2019-09-16 |
2021-03-25 |
Dice Alpha, Inc. |
Modulateurs d'il-17a et leurs utilisations
|
WO2021067644A1
(fr)
|
2019-10-01 |
2021-04-08 |
Silverback Therapeutics, Inc. |
Polythérapie comprenant des conjugués immunostimulants
|
KR20220150270A
(ko)
|
2019-10-07 |
2022-11-10 |
칼리오페, 인크. |
Gpr119 효능제
|
WO2021072330A1
(fr)
|
2019-10-09 |
2021-04-15 |
Silverback Therapeutics, Inc. |
CONJUGUÉS DE GALNAC ET D'UN INHIBITEUR DE TGFβR1 POUR LE TRAITEMENT DE MALADIES HÉPATIQUES
|
US20210130473A1
(en)
|
2019-10-09 |
2021-05-06 |
Silverback Therapeutics, Inc. |
TGFßR1 INHIBITOR-ASGR ANTIBODY CONJUGATES AND USES THEREOF
|
US11098031B1
(en)
|
2019-10-24 |
2021-08-24 |
Kinnate Biopharma Inc. |
Inhibitors of RAF kinases
|
WO2021102332A1
(fr)
|
2019-11-22 |
2021-05-27 |
Silverback Therapeutics, Inc. |
Conjugués inhibiteur de tgfbetar2-anticorps anti-lrrc15 et leurs utilisations
|
US20230038929A1
(en)
|
2019-12-05 |
2023-02-09 |
Verge Analytics, Inc. |
Fused Tricyclic Heterocyclic Compounds and Uses Thereof
|
MX2022008627A
(es)
|
2020-01-13 |
2022-11-08 |
Verge Analytics Inc |
Pirazolo-pirimidinas sustituidas y usos de las mismas.
|
EP4100393A1
(fr)
|
2020-02-07 |
2022-12-14 |
Cytokinetics, Inc. |
Modulateurs de nampt
|
US11807851B1
(en)
|
2020-02-18 |
2023-11-07 |
Ultima Genomics, Inc. |
Modified polynucleotides and uses thereof
|
JP2023514727A
(ja)
|
2020-02-21 |
2023-04-07 |
シルバーバック セラピューティックス インコーポレイテッド |
ネクチン-4抗体コンジュゲートおよびその使用
|
EP4118087A1
(fr)
|
2020-03-09 |
2023-01-18 |
Verge Analytics, Inc. |
Furo[3,2-d]pyrimidines substituées et leurs utilisations
|
WO2021195260A1
(fr)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Inhibiteur de lpxc et procédés de fabrication
|
IL297929A
(en)
|
2020-05-04 |
2023-01-01 |
Volastra Therapeutics Inc |
Imino sulfanone inhibitors of enpp1
|
WO2021226276A2
(fr)
|
2020-05-06 |
2021-11-11 |
Cytokinetics, Inc. |
Modulateurs de nampt
|
WO2021231630A1
(fr)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Pyridazinone substituée destinée à être utilisée dans le traitement d'infections neuromusculaire
|
EP4149467A1
(fr)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Pyridazinone substituée destinée à être utilisée dans le traitement de maladies neuromusculaires
|
WO2021231572A1
(fr)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Composés pyridazinone pour le traitement de maladies neuromusculaires
|
WO2021231565A1
(fr)
|
2020-05-13 |
2021-11-18 |
Edgewise Therapeutics, Inc. |
Composés de pyridazinone pour le traitement de troubles neuromusculaires
|
EP4149465A1
(fr)
|
2020-05-13 |
2023-03-22 |
Edgewise Therapeutics, Inc. |
Pyridazinone substituée destinée à être utilisée dans le traitement de maladies neuromusculaires
|
JP2023526050A
(ja)
|
2020-05-14 |
2023-06-20 |
ヴィア・バイオテクノロジー・インコーポレイテッド |
Enpp1モジュレーターおよびその使用
|
EP4153589A1
(fr)
|
2020-05-19 |
2023-03-29 |
Kallyope, Inc. |
Activateurs d'ampk
|
MX2022015410A
(es)
|
2020-06-05 |
2023-03-13 |
Kinnate Biopharma Inc |
Inhibidores de las cinasas receptoras del factor de crecimiento de fibroblastos.
|
TW202214640A
(zh)
|
2020-06-16 |
2022-04-16 |
美商佛拉斯托醫療公司 |
Enpp1之雜環抑制劑
|
CA3183575A1
(fr)
|
2020-06-26 |
2021-12-30 |
Iyassu Sebhat |
Activateurs d'ampk
|
US11319313B2
(en)
|
2020-06-30 |
2022-05-03 |
Poxel Sa |
Crystalline forms of deuterium-enriched pioglitazone
|
US11767317B1
(en)
|
2020-06-30 |
2023-09-26 |
Poxel Sa |
Methods of synthesizing enantiopure deuterium-enriched pioglitazone
|
CA3183993A1
(fr)
|
2020-07-01 |
2022-01-06 |
Peter R. Baum |
Conjugues d'anticorps anti-asgr1 et leurs utilisations
|
WO2022020522A2
(fr)
|
2020-07-21 |
2022-01-27 |
Aeovian Pharmaceuticals, Inc. |
Modulateurs de mtorc1 et leurs utilisations
|
EP4196219A1
(fr)
|
2020-08-17 |
2023-06-21 |
Biointervene, Inc. |
Analogues du récepteur a3 de l'adénosine pour le traitement d'une maladie
|
JP2023535329A
(ja)
*
|
2020-08-27 |
2023-08-17 |
エルジー・ケム・リミテッド |
重水素化芳香族化合物の製造方法および重水素化反応組成物
|
CN111995574B
(zh)
*
|
2020-08-28 |
2024-05-17 |
西安明喆药品生产有限公司 |
氘代羟氯喹衍生物以及包含该化合物的药物组合物
|
WO2022060996A1
(fr)
|
2020-09-18 |
2022-03-24 |
Kinnate Biopharma Inc. |
Inhibiteurs de raf kinases
|
WO2022081469A1
(fr)
|
2020-10-12 |
2022-04-21 |
Kinnate Biopharma Inc. |
Inhibiteurs de kinases raf
|
US11981644B2
(en)
|
2020-11-06 |
2024-05-14 |
Cytokinetics, Inc. |
Bicyclic 1,4-diazepanones and therapeutic uses thereof
|
EP4247794A2
(fr)
|
2020-11-20 |
2023-09-27 |
2692372 Ontario, Inc. |
Dérivés de benzènesulfonamide et leurs utilisations
|
CA3198344A1
(fr)
|
2020-11-20 |
2022-05-27 |
Patrick T. GUNNING |
Procedes et composition pour effectuer des modifications de kras
|
US20240067631A1
(en)
|
2020-12-21 |
2024-02-29 |
Cytokinetics, Inc. |
Pyrazole derivatives useful as nampt modulators
|
WO2022169882A1
(fr)
|
2021-02-03 |
2022-08-11 |
Verge Analytics, Inc. |
Procédés et traitement d'une infection virale provoquée par le sars-cov-2
|
CN117222641A
(zh)
|
2021-02-24 |
2023-12-12 |
英矽智能科技知识产权有限公司 |
用于治疗疾病的类似物
|
AU2022229390A1
(en)
|
2021-03-04 |
2023-09-21 |
Cytokinetics, Inc. |
Cardiac sarcomere inhibitors
|
US11459351B1
(en)
|
2021-04-05 |
2022-10-04 |
Azura Ophthalmics Ltd. |
Compounds and methods for the treatment of ocular disorders
|
EP4320103A1
(fr)
|
2021-04-09 |
2024-02-14 |
Quanta Therapeutics, Inc. |
Modulateurs de ras à base de pyrimidine et leurs utilisations
|
IL307880A
(en)
*
|
2021-04-23 |
2023-12-01 |
Gilgamesh Pharmaceuticals Inc |
New ergolines and methods for treating mood disorders
|
AU2022261117A1
(en)
|
2021-04-23 |
2023-11-23 |
Kinnate Biopharma Inc. |
Treatment of cancer with a raf inhibitor
|
WO2022256298A1
(fr)
|
2021-06-01 |
2022-12-08 |
Verge Analytics, Inc. |
Dérivés de 7-(3-phényl-1h-pyrazol-1-yl)-5-morpholino-imidazo[1,2-a]pyrimidine et composés similaires utilisés en tant qu'inhibiteurs de la pikfyve kinase pour le traitement, par exemple, de la sclérose latérale amyotrophique (als)
|
WO2022256297A1
(fr)
|
2021-06-01 |
2022-12-08 |
Verge Analytics, Inc. |
Dérivés de 2-(3-phényl-1h-pyrazol-1-yl)-4-morpholino-5h-pyrrolo[3,2-d]pyrimidine et de composés similaires en tant qu'inhibiteurs de la pikfyve kinase pour le traitement, par exemple, de la sclérose latérale amyotrophique (sla)
|
TW202313619A
(zh)
|
2021-06-01 |
2023-04-01 |
美商邊際分析公司 |
稠合雙環雜環化合物及其用途
|
AR126010A1
(es)
|
2021-06-01 |
2023-08-30 |
Verge Analytics Inc |
Compuestos heterocíclicos bicíclicos fusionados y usos de los mismos
|
TW202313051A
(zh)
|
2021-06-08 |
2023-04-01 |
美商邊際分析公司 |
使用經取代呋喃并嘧啶之病毒感染治療及方法
|
WO2022263829A1
(fr)
|
2021-06-16 |
2022-12-22 |
Z Factor Limited |
Composés et leur utilisation pour le traitement du déficit en alpha1-antitrypsine
|
AU2022298746A1
(en)
|
2021-06-24 |
2023-11-30 |
Insilico Medicine Ip Limited |
Beta-lactam derivatives for the treatment of diseases
|
EP4366829A1
(fr)
|
2021-07-09 |
2024-05-15 |
Dice Alpha, Inc. |
Modulateurs d'il-17a à base de phényle acétamide et utilisations associées
|
CA3225785A1
(fr)
|
2021-07-12 |
2023-01-19 |
Cytokinetics, Inc. |
Modulateurs de cd38 et leurs procedes d'utilisation
|
TW202317092A
(zh)
|
2021-08-26 |
2023-05-01 |
美商佛拉斯托醫療公司 |
Kif18a之吲哚啉抑制劑
|
WO2023070114A2
(fr)
|
2021-10-22 |
2023-04-27 |
Terremoto Biosciences, Inc. |
Modificateurs covalents de lysine réversibles de l'egfr et leurs utilisations
|
WO2023076866A1
(fr)
|
2021-10-25 |
2023-05-04 |
Volastra Therapeutics, Inc. |
Inhibiteurs sulfoximines tricycliques d'enpp1
|
WO2023081312A1
(fr)
|
2021-11-04 |
2023-05-11 |
Vir Biotechnology, Inc. |
Inducteurs à petites molécules d'autophagie
|
WO2023083286A1
(fr)
|
2021-11-12 |
2023-05-19 |
Insilico Medicine Ip Limited |
Inhibiteurs à petites molécules de la protéase 1 ubiquitine-spécifique et leurs utilisations
|
WO2023086638A1
(fr)
|
2021-11-15 |
2023-05-19 |
Vir Biotechnology, Inc. |
Modulateurs de l'enpp1 et leurs utilisations
|
WO2023091606A1
(fr)
|
2021-11-17 |
2023-05-25 |
Edgewise Therapeutics, Inc. |
Composés de pyridazinone et leurs utilisations
|
WO2023114733A1
(fr)
|
2021-12-13 |
2023-06-22 |
Quanta Therapeutics, Inc. |
Modulateurs de kras et leurs utilisations
|
US11753395B2
(en)
|
2021-12-16 |
2023-09-12 |
Kinnate Biopharma Inc. |
Inhibitors of MET kinase
|
WO2023114428A1
(fr)
|
2021-12-16 |
2023-06-22 |
Vir Biotechnology, Inc. |
Dérivés hétérocycliques pour le traitement d'une maladie
|
WO2023150681A1
(fr)
|
2022-02-03 |
2023-08-10 |
Kinnate Biopharma Inc. |
Inhibiteurs de raf kinases
|
WO2023154766A1
(fr)
|
2022-02-09 |
2023-08-17 |
Quanta Therapeutics, Inc. |
Modulateurs de kras et leurs utilisations
|
TW202345807A
(zh)
|
2022-02-25 |
2023-12-01 |
美商戴斯阿爾法股份有限公司 |
基於二環丙基之il-17a調節劑及其用途
|
WO2023168291A1
(fr)
|
2022-03-02 |
2023-09-07 |
Terremoto Biosciences, Inc. |
Modificateurs covalents de akt1 et leurs utilisations
|
TW202342018A
(zh)
|
2022-03-04 |
2023-11-01 |
美商奇奈特生物製藥公司 |
Mek激酶抑制劑
|
WO2023178144A2
(fr)
|
2022-03-16 |
2023-09-21 |
Empirico Inc. |
Compositions de galnac pour améliorer la biodisponibilité de l'arnsi
|
WO2023198873A1
(fr)
*
|
2022-04-14 |
2023-10-19 |
Immunic Ag |
Agonistes inverses de rorgamma/rorgammat deutérés
|
TW202346288A
(zh)
|
2022-04-28 |
2023-12-01 |
美商佛拉斯托醫療公司 |
用於抑制kif18a之化合物
|
WO2023215367A1
(fr)
|
2022-05-04 |
2023-11-09 |
Cytokinetics, Inc. |
Pipérazinones bicycliques et leurs utilisations thérapeutiques
|
WO2023220741A1
(fr)
|
2022-05-13 |
2023-11-16 |
Dice Molecules Sv, Inc. |
Modulateurs de l'intégrine alpha 4 bêta 7 et leurs utilisations
|
WO2023225001A1
(fr)
|
2022-05-16 |
2023-11-23 |
Vir Biotechnology, Inc. |
Modulateurs d'enpp1 à base de naphtyridine et leurs utilisations
|
US11939335B2
(en)
|
2022-05-17 |
2024-03-26 |
858 Therapeutics, Inc. |
Substituted imidazo[1,2-a]quinazolines and imidazo [1,2-a]pyrido[4,3-e]pyrimidines as inhibitors of PARG
|
WO2023225664A1
(fr)
|
2022-05-19 |
2023-11-23 |
Dice Alpha, Inc. |
Modulateurs d'il-17a tels que l'imidazopyridazine à substitution lactame et leurs utilisations
|
WO2023230190A1
(fr)
|
2022-05-25 |
2023-11-30 |
Quanta Therapeutics, Inc. |
Modulateurs à base de pyrimidine et leurs utilisations
|
WO2023235880A1
(fr)
|
2022-06-02 |
2023-12-07 |
Aeovian Pharmaceuticals, Inc. |
Modulateurs de cd38 et leurs utilisations
|
WO2023240253A2
(fr)
|
2022-06-10 |
2023-12-14 |
Forward Therapeutics, Inc. |
Modulateurs de l'activité du tnf-alpha
|
WO2023245137A1
(fr)
|
2022-06-16 |
2023-12-21 |
Cytokinetics, Incorporated |
Activateurs de troponine à squelette lent
|
WO2024020380A1
(fr)
|
2022-07-18 |
2024-01-25 |
Iambic Therapeutics, Inc. |
Composés de quinazoline et procédés d'utilisation
|
WO2024020419A1
(fr)
|
2022-07-18 |
2024-01-25 |
Iambic Therapeutics, Inc. |
Composés d'aza-quinazoline et procédés d'utilisation
|
US20240101544A1
(en)
|
2022-07-22 |
2024-03-28 |
James M. Veal |
Inhibitors of qpctl and qpct
|
WO2024030825A1
(fr)
|
2022-08-01 |
2024-02-08 |
Neupharma, Inc |
Sels cristallins de sels cristallins de (3s,5r,8r,9s,10s,13r,14s,17r)-14-hydroxy-10,13-diméthyl-17-(2-oxo-2h-pyran-5-yl)hexadécahydro-1h-cyclopenta[a]phénanthren-3-yl pipérazine-1-carboxylate
|
WO2024040190A1
(fr)
|
2022-08-18 |
2024-02-22 |
Cytokinetics, Incorporated |
Dérivés d'indane et de coumarane utilisés en tant qu'inhibiteurs de myosine du muscle squelettique rapide
|
WO2024064701A2
(fr)
|
2022-09-20 |
2024-03-28 |
Biointervene, Inc. |
Analogues d'adénosine pour le traitement de maladies
|
WO2024073426A1
(fr)
|
2022-09-26 |
2024-04-04 |
Edgewise Therapeutics, Inc. |
Composés de 1,4-dihydroquinazolinone et utilisations associées
|